Literature DB >> 7635953

Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.

N E Cameron1, M A Cotter.   

Abstract

Oxygen free radical activity is elevated in diabetes mellitus and has been implicated in the etiology of vascular complications. Recent studies have shown that impaired perfusion of nerve endoneurium is a major cause of nerve fiber dysfunction in experimental diabetes. Free radical scavenger treatment prevents the development of nerve conduction abnormalities in diabetic rats. In vitro experiments suggest that autoxidation reactions of glucose, catalyzed by free transition metal ions, are a potential source of free radicals in diabetes. We investigated whether chronic treatment with deferoxamine and trientine, transition metal chelating agents which can prevent autoxidation, could correct nerve conduction and blood flow changes in streptozotocin-diabetic rats. A 20% reduction in sciatic nerve motor conduction velocity after 2 mo diabetes was 90% ameliorated by 2 wk of treatment with deferoxamine or trientine. Sciatic endoneurial nutritive blood flow was 45% reduced by diabetes, but was completely corrected by treatment. In contrast, transition metal chelation had no effect on blood flow or conduction velocity in nondiabetic rats. Thus, the data support the hypothesis that increased free radical activity by glucose autoxidation as a result of impaired transition metal handling is a major cause of early neurovascular deficits in diabetes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635953      PMCID: PMC185307          DOI: 10.1172/JCI118104

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

Review 1.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

2.  Abnormal glutathione metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium.

Authors:  A Kashiwagi; T Asahina; M Ikebuchi; Y Tanaka; Y Takagi; Y Nishio; R Kikkawa; Y Shigeta
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

3.  Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.

Authors:  N E Cameron; M A Cotter; K C Dines; E K Maxfield
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

4.  Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; V Archibald; K C Dines; E K Maxfield
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

5.  Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; E K Maxfield
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

6.  The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

Authors:  M J Stevens; J Dananberg; E L Feldman; S A Lattimer; M Kamijo; T P Thomas; H Shindo; A A Sima; D A Greene
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve.

Authors:  M Kihara; P J Zollman; I L Smithson; T D Lagerlund; P A Low
Journal:  Am J Physiol       Date:  1994-06

8.  Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.

Authors:  A C Kappelle; G Biessels; B Bravenboer; T van Buren; J Traber; D J de Wildt; W H Gispen
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.

Authors:  N E Cameron; M A Cotter; K C Dines; E K Maxfield; F Carey; D J Mirrlees
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

10.  Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.

Authors:  N A Calcutt; A P Mizisin; M W Kalichman
Journal:  Eur J Pharmacol       Date:  1994-01-04       Impact factor: 4.432

View more
  30 in total

Review 1.  Transition metals redox: reviving an old plot for diabetic vascular disease.

Authors:  V M Monnier
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

3.  Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.

Authors:  Angelika Bierhaus; Karl-Matthias Haslbeck; Per M Humpert; Birgit Liliensiek; Thomas Dehmer; Michael Morcos; Ahmed A R Sayed; Martin Andrassy; Stephan Schiekofer; Jochen G Schneider; Jörg B Schulz; Dieter Heuss; Bernhard Neundörfer; Stefan Dierl; Jochen Huber; Hans Tritschler; Ann-Marie Schmidt; Markus Schwaninger; Hans-Ulrich Haering; Erwin Schleicher; Michael Kasper; David M Stern; Bernd Arnold; Peter P Nawroth
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.

Authors:  Chun-Yan Wang; Jing-Wei Xie; Ye Xu; Tao Wang; Jian-Hui Cai; Xu Wang; Bao-Lu Zhao; Li An; Zhan-You Wang
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

5.  Comparison of the effects of ascorbyl gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats.

Authors:  N E Cameron; M A Cotter
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

6.  Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.

Authors:  L K Bhatt; Addepalli Veeranjaneyulu
Journal:  Neurol Sci       Date:  2010-03-06       Impact factor: 3.307

7.  Glucose autoxidation induces functional damage to proteins via modification of critical arginine residues.

Authors:  Sergei Chetyrkin; Missy Mathis; Vadim Pedchenko; Otto A Sanchez; W Hayes McDonald; David L Hachey; Hartman Madu; Donald Stec; Billy Hudson; Paul Voziyan
Journal:  Biochemistry       Date:  2011-06-20       Impact factor: 3.162

8.  Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy.

Authors:  John W Eaton; Mingwei Qian
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 9.  Oxidative stress and diabetic vascular complications.

Authors:  Seok Man Son; Matthew K Whalin; David G Harrison; W Robert Taylor; Kathy K Griendling
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 10.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.